Topics

Human medicines European public assessment report (EPAR): Levodopa/Carbidopa/Entacapone Orion, levodopa / carbidopa / entacapone, Parkinson Disease, Date of authorisation: 23/08/2011, Revision: 10, Status: Authorised

11:33 EDT 13 Sep 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Levodopa/Carbidopa/Entacapone Orion, levodopa / carbidopa / entacapone, Parkinson Disease, Date of authorisation: 23/08/2011, Revision: 10, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Levodopa/Carbidopa/Entacapone Orion, levodopa / carbidopa / entacapone, Parkinson Disease, Date of authorisation: 23/08/2011, Revision: 10, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Levodopa/Carbidopa/Entacapone Orion, levodopa / carbidopa / entacapone, Parkinson Disease, Date of authorisation: 23/08/2011, Revision: 10, Status: Authorised"

Quick Search

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...